The portal venous system refers to the veins that drain blood from the intestines, stomach, pancreas, esophagus and spleen into the liver prior to entering the main or systemic circulation. All ...

The prevalence of Portal Vein Thrombosis (PVT) varies significantly at different stages of liver disease: 10% in compensated patients, 17% in decompensated patients, 9% in those with acute ...

May 13, 2010 — Eltrombopag (Promacta; GlaxoSmithKline) has been linked to an increased risk for portal venous thrombosis in patients with thrombocytopenia due to chronic liver disease, and the company ...

Actively identifying the risk factors and predictive indicators associated with portal vein thrombosis (PVT) in liver cirrhosis (LC) can enable early diagnosis and treatment, which is of great ...

Doppler ultrasonography is the first imaging technique to be used for portal vein thrombosis (PVT) diagnosis; it is well-tolerated, accurate and a negative examination performed by a trained operator ...

GlaxoSmithKline and the FDA notified healthcare professionals of a new safety finding in patients with thrombocytopenia due to chronic liver disease treated with Promacta (eltrombopag tablets). The ...

SHORTLY after Abeatici and Campi, 1 in 1951, introduced direct percutaneous splenic puncture as a method of performing splenoportal venography in dogs this became the standard roentgenographic method ...

Portal Hypertension Symptoms and Their ComplicationsPortal hypertension is a condition in which increased pressure within the portal vein—an important vessel that carries blood from the stomach and ...

Common complications of nephrotic syndrome include infections, development of a hypercoagulable state, and venous thrombosis. [1] Venous thrombosis occurs most often in the renal veins and in the ...

Portal hypertension is one of the main consequences of cirrhosis. It results from a combination of increased intrahepatic vascular resistance and increased blood flow through the portal venous system.